01 Internal and External Specialisms

Research output

Research output per year 1978 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 10625 Article
• 931 Review article
• 484 Meeting Abstract
• 398 Comment/Letter to the editor
• 1081 More
  • 302 Chapter
  • 281 Letter
  • 161 Editorial
  • 121 Phd-Thesis - Research and graduation internal
  • 51 Conference contribution
  • 33 Short survey
  • 26 Erratum/Corrigendum
  • 25 Book
  • 23 Poster
  • 16 Report
  • 11 Paper
  • 8 Abstract
  • 6 Inaugural speech
  • 5 Foreword/postscript
  • 5 Phd-Thesis - Research and graduation external
  • 4 Book editing
  • 1 Book/Film/Article review
  • 1 Patent
  • 1 Working paper

Research output per year

Research output per year

Search results

• 2020

  1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes

  Bahce, I., Hashemi, SMS., Fransen, MF., Veltman, JD. & Thunnissen, FBJM., 2020, p. S883.

  Research output: Contribution to conference › Poster › Academic

• 766P - Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

  Voortman, J., 17 Sept 2020.

  Research output: Contribution to conference › Poster › Academic

• 89Zr-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.

  Voortman, J., 2020.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.

  Voortman, J., 2020.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Early response marker during pembrolizumab treatment in metastatic urothelial cancer: Temporal shift in peripheral CD4 T cells expressing chemokine receptors.

  Voortman, J., 2020.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• PO-0996: Early mortality in stage III NSCLC after radical non-surgical therapy following ESMO guidelines

  Ronden-Kianoush, M., de Vries, I. F. R., Bahce, I., De Haan, P. F., Tiemessen, M. A., Spoelstra, F. O. B., Van Diepen, V. D. M., Haasbeek, C. J. A., Tarasevych, S., Daniels, H. J. M. A., Dahele, M. R., Hashemi, S. M., Becker, A., Veltman, J. D., Crombag, L. M. M., Senan, S. & Verbakel, W. F. A. R., 2020, p. S531-S532.

  Research output: Contribution to conference › Poster › Academic
• 2019

  CEREBRAL OXYGEN METABOLISM MEASUREMENTS WITH MRI IN ADULTS WITH SICKLE CELL DISEASE

  Vaclavu, L., Petersen, E., Mutsaerts, H., Petr, J., Majoie, C., Wood, J., VanBavel, E., Nederveen, A. & Biemond, B., Jun 2019, p. 324-325. 2 p.

  Research output: Contribution to conference › Poster › Academic
• 2018

  NLSEV2018-P21 - EV-derived microRNA profiles from patients with classical Hodgkin Lymphoma can discriminate between active disease and complete response

  Voortman, J., 2018.

  Research output: Contribution to conference › Poster › Academic
• 2017

  [18F]FLUORO-PEG-FOLATE PET: A NOVEL IMAGING TECHNIQUE TO VISUALIZE RHEUMATOID ARTHRITIS

  Verweij, N., Bruijnen, S., Gent, Y., Huisman, M., Jansen, G., Molthoff, C., Chen, Q., Low, P., Windhorst, A., Lammertsma, A., Hoekstra, O., Voskuyl, A. & van der Laken, C., Jun 2017, p. 1020-1021.

  Research output: Contribution to conference › Poster › Academic

• 2964 - Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

  Voortman, J., 10 Sept 2017.

  Research output: Contribution to conference › Poster › Academic

• A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

  Voortman, J., 2017.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• CARDIOVASCULAR EVENTS IN ANCA-ASSOCIATED VASCULITIS: A META-ANALYSIS OF OBSERVATIONAL STUDIES

  Houben, E., Penne, E. L., Voskuyl, A. E., van der Heijden, J. W., Boers, M. & Hoekstra, T., Jun 2017, p. 604-604.

  Research output: Contribution to conference › Poster › Academic

• DIETARY PROTEIN INTAKE AND UPPER LEG MUSCLE STRENGTH IN PATIENTS WITH KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE

  de Zwart, A. H., van der Leeden, M., Roorda, L. D., Visser, M., van der Esch, M., Lems, W. F. & Dekker, J., Jun 2017, p. 1488-1488.

  Research output: Contribution to conference › Poster › Academic

• IN VIVO MONITORING OF ANTI-FOLATE THERAPY IN ARTHRITIC RATS USING [18F]FLUORO-PEG-FOLATE AND PET

  Chandrupatla, D. M. S. H., van der Laken, C. J., Vos, R., Verlaan, M., van Kooij, R., Windhorst, A. D., Chen, Q., Low, P. S., Lammertsma, A. A., Jansen, G. & Molthoff, C. F. M., Jun 2017, p. 494-494.

  Research output: Contribution to conference › Poster › Academic

• REPAIR OF JOINT DAMAGE IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS PATIENTS OCCURS BUT DOES NOT RELATE TO PREVIOUS SUPPRESSION OF INFLAMMATION; AN 8-YEARS SUB ANALYSIS IN THE BEST-COHORT

  van der Pol, J. A., Akdemir, G., van den Broek, M., Dirven, L., Kerstens, P., Lems, W. F., Markusse, I. M., Allaart, C. F. & Huizinga, T. W., Jun 2017, p. 516-516.

  Research output: Contribution to conference › Poster › Academic
• 2016

  S471 SKELETAL MUSCLE MASS MEASUREMENTS AND ASSOCIATION WITH TREATMENT OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY

  Voortman, J., 2016.

  Research output: Contribution to conference › Poster › Academic
• 2014

  A phase I study of DMOT4039A, an antibody-drug conjugate (ADC) targeting mesothelin (MSLN), in patients (pts) with unresectable pancreatic (PC) or platinum-resistant ovarian cancer (OC).

  Voortman, J., 2014.

  Research output: Contribution to conference › Poster › Academic

  Open Access
• 2012

  Titel resultaat: Power of the past: a randomized controlled trial testing the efficacy

  Kleijn, G., de Bree, R., Leemans, C. R., Becker, A., Smit, E. F., Eeltink, C. M., Bruynzeel, A. M. E., van den Brekel, M., Steunenberg, B., Bohlmeijer, E., Willemsen, V. W. B., Cuijpers, P. & de Leeuw, I. M., 2012.

  Research output: Contribution to conference › Poster › Other research output
• 2011

  Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer.

  Voortman, J., 2011.

  Research output: Contribution to conference › Poster › Academic
• 2010

  Abstract 2995: MicroRNA expression and outcome of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program (IALT-Bio)

  Voortman, J., 2010.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Abstract 3000: MicroRNA-21 as a biomarker for benefit from adjuvant therapy in resectable pancreatic adenocarcinoma

  Voortman, J., 2010.

  Research output: Contribution to conference › Poster › Academic

  Open Access
• 2009

  P038 Decreased expression of CD62L, CD54 and CXCR4 in CD34pos cells adds to the pro-apoptotic profile in low risk and myelodysplastic syndromes

  Alhan, C., Cali, C., Kessler, F., Terwijn, M., Ossenkoppele, G., Zweegman, S., Westers, T. & van de Loosdrecht, A., May 2009.

  Research output: Contribution to conference › Poster › Academic
• 2008

  The heritability of HbA1c and fasting glucose is caused by different genetic factors

  Simonis-Bik, A. M. C., Eekhoff, E. M. W., Diamant, M., Boomsma, D. I., Heine, R. J., Dekker, J. M., Willemsen, G., van Leeuwen, M. & de Geus, E. J. C., 2008.

  Research output: Contribution to conference › Poster › Other research output